In vitro and in vivo study of the effects of enrofloxacin on hepatic cytochrome P-450. Potential for drug interactions

Veterinary and Human Toxicology

Volumn 38, Issue 4, 1996, Pages 254-259

  Vancutsem, Paul M ^a,c   Babish, John G ^b  

^a Department of Obstetrics Gynecology   (United States)

^b Cornell Technology Park ^*  (United States)

^c UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOCHROME P450; ENROFLOXACIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERICIDAL ACTIVITY; BIOTRANSFORMATION; CONTROLLED STUDY; DEALKYLATION; DRUG EFFECT; DRUG INHIBITION; ENZYME ACTIVITY; IN VITRO STUDY; IN VIVO STUDY; LIVER METABOLISM; LIVER MICROSOME; NONHUMAN; RAT; VETERINARY MEDICINE;

ANIMALS; ANTI-INFECTIVE AGENTS; CYTOCHROME P-450 CYP1A1; CYTOCHROME P-450 CYP2B1; CYTOCHROME P-450 ENZYME SYSTEM; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INTERACTIONS; ELECTROPHORESIS, POLYACRYLAMIDE GEL; FLUOROQUINOLONES; IMMUNOBLOTTING; LIVER; MALE; NADH DEHYDROGENASE; NADP; OXIDOREDUCTASES; QUINOLONES; RATS; RATS, SPRAGUE-DAWLEY;

ANIMALIA;

EID: 0029781095     PISSN: 01456296     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Vancutsem PM, Babish JG, Schwark WS: The fluoroquinolone antimicrobials: Structure, antimicrobial activity, pharmacokinetics, clinical use in domestic animals and toxicity. Cornell Vet 80: 173-186, 1990.
2. Niki Y, Soejima R, Kawane H et al: New synthetic quinolone antibacterial agents and serum concentration of theophylline. Chest 92: 663-669, 1987.
3. Staib AH, Harder S, Mieke S et al: Gyrase-inhibitors impair caffeine elimination in man. Methods Find Exp Clin Pharmacol 9: 193-198, 1987.
4. Sano M, Kawakatsu K, Ohkita C et al: Effects of enoxacin, ofloxacin and norfloxacin on theophylline disposition in humans. Eur J Clin Pharmacol 35: 161-165, 1988.
5. Nakashi S, Okuno H: Comparison of inhibitory effects of new quinolones on drug metabolizing activity in the liver. Jpn J Pharmacol 53: 81-96, 1990.
6. Fuhr U, Staib AH: Inhibition of P450IA2 by quinolone antimicrobials. Antimicrob Agents Chemother 36: 945-948, 1992.
7. Fuhr U, Wolff T, Harder S et al: Quinolone inhibition of cytochrome P-450-dependent caffeine metabolism in human liver microsomes. Drug Metab Dispos 18: 1005-1010, 1990.
8. Schulz-Schlage T, Stahlman R, Edwards RJ et al: Enoxacin but not ciprofloxacin or ofloxacin is an inducer of P450 IA2 in hepatic microsomes of Wistar rats. International Society for the Study of Xenobiotics, Proceedings 2: 134, 1992 (Abstr).
9. Nelson SD, Harvison PJ: Roles of cytochromes P-450 in chemically induced cytotoxicity. In Guengerich FP, ed: Mammalian Cytochromes P-450, Vol II. CRC Press, Boca Raton: 19-80, 1987.
10. Novotny MJ, Shaw DH: Effect of enrofloxacin on digoxin clearance and steady-state serum concentrations in dogs. Can J Vet Res 55: 113-116, 1991.
11. Vancutsem PM, Babish JG: Effects of ciprofloxacin and enrofloxacin on zoxazolamine kinetics, plasma concentration and sleeping times in mice. Toxicol Lett 69: 1-14, 1993.
12. Butler MA, Iwasaki M, Guengerich FP et al: Human cytochrome P-450pa (P-450IA2), the phenacetin O-deethylase, is primarily responsible for the hepatic 3-demethylation of caffeine and N-oxidation of carcinogenic arylamines. Proc Natl Acad Sci USA 86: 7696-7700, 1989.
13. Robson RA, Miners JO, Matthews AP et al: Characterization of theophylline metabolism by human liver microsomes. Inhibition and immunochemical studies. Biochem Pharmacol 37: 1651-1659, 1988.
14. Guengerich FP: Enzymology of rat liver cytochromes P450. In Guengerich FP ed: Mammalian Cytochromes P-450, Vol I. CRC Press, Boca Raton: 2-54, 1987.
15. De Duve C, Wattiaux R, Baudhuin P: Distribution of enzymes between subcellular fractions in animal tissues. Adv Enzymol 24: 291-358, 1962.
16. Smith PK, Krohn RI, Hermanson GT et al: Measurements of protein using bichinchonic acid [published erratum appears in Analytical Biochemistry 1987 May 15: 163 (1): 279]. Anal Biochem 150: 76-85, 1987.
17. Omura T, Sato R: The carbon monoxide-binding pigment of liver microsomes. II. Solubilization, purification and properties. J Biol Chem 239: 2379-2385, 1964.
18. Strittmater P, Velick SF: The purification and properties of microsomal cytochrome reductase. J Biol Chem 228: 785-799, 1957.
19. Williams CH, Kamin H: Microsomal triphosphopyridine nucleotide-cytochrome c reductase of liver. J Biol Chem 237: 587-595, 1962.
20. Burke MD, Thompson S, Elcombe CR et al: Ethoxy-, pentoxy- and benzoxyphenoxazones and homologues: A series of substrates to distinguish between different induced cytochromes P-450. Biochem Pharmacol 34: 3337-3345, 1985.
21. Okey AB: Enzyme induction in the cytochrome P-450 system. Pharmacol Ther 45: 241-298, 1989.
22. Laemmli UK, Favre M: Maturation of the head of bacteriophage T4. I. DNA packaging events. J Mol Biol 80: 575-599, 1973.
23. Towbin H, Staehelin T, Gordon J: Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: Procedure and some applications. Proc Natl Acad Sci USA 76: 4350-4354, 1979.
24. Friedman FK, Miller H, Park SS et al: Induction of rat liver microsomal and nuclear cytochrome P-450 by dietary 2-acetylaminofluorene and butylated hydroxytoluene. Biochem Pharmacol 38: 3075-3081, 1989.
25. Forkert PG, Mirehouse Brown P, Park SS et al: Distribution and induction sites of phenobarbital- and 3-methylcholanthrene-inducible cytochromes P-450 in murine liver: Immunohistochemical localization with monoclonal antibodies. Mol Pharmacol 34: 736-743, 1988.
26. Wolf CR, Moll E, Friedberg T et al: Characterization, localization and regulation of a novel phenobarbital-inducible form of cytochrome P450, compared with three further P450-isoenzymes, NADPH P450 reductase, glutathione transferases and microsomal epoxide hydrolase. Carcinogenesis 5: 993-1001, 1984.
27. Burke MD, Mayer RT: Inherent specificities of purified cytochromes P-450 and P-448 toward biphenyl hydroxylation and ethoxyresorufin deethylation. Drug Metab Dispos 3: 245-253, 1975.
28. Scheer M: Concentrations of active ingredient in the serum and in tissues after oral and parenteral administration of Baytril. Vet Med Rev 2: 104-118, 1987.
29. Schweizer M, Peter MA, Filipovic D et al: Mechanism of monoclonal antibody inhibition/stimulation of reactions catalyzed by cytochrome P450IIB1. Arch Biochem Biophys 288: 64-70, 1991.
30. Li Y, Wang E, Patten C et al: Effects of flavonoids on cytochrome P450-dependent acetaminophen metabolism in rats and human liver microsomes. Drug Metab Dispos 22: 566-571, 1991.
31. Walker RD, Stein GE, Hauptman JG et al: Pharmacokinetic evaluation of enrofloxacin administered orally to healthy dogs. Am J Vet Res 53: 2315-2319, 1992.
32. Yang H-YL, Namkung MJ, Juchau MR: Cytochrome P-450-dependent biotransformation of a series of phenoxazone ethers in the rat conceptus during early organogenesis: Evidence for multiple P-450 isoenzymes. Mol Pharmacol 34: 67-73, 1988.
33. Rodrigues AD, Prough RA: Induction of cytochromes PP450Ia1 and P450IA2 and measurements of catalytic activities. In Waterman MR, Johnson EF eds: Cytochrome P450. Academic Press Inc, San Diego: 423-431, 1991 .
34. Grech-Belanger O, Francoeur J, Le Bel M: The effects of fleroxacin on hepatic drug metabolism in the rat. Res Commun Chem Pathol Pharmacol 64: 121-133, 1989.